Tetra Bio-Pharma 

$0
19
-$0-99.5% Wednesday 13:30

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
-
Avg. Volume
-
Mkt Cap
423.36
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31OctExpected
Q4 0
Q1 2024
Q2 2024
Q3 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-82.15MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TBPMQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.
Show more...
CEO
Dr. Guy Chamberland M.Sc., Master Herbal
Employees
33
Country
Canada
ISIN
CA88166Y1007

Listings

0 Comments

Share your thoughts

FAQ

What is Tetra Bio-Pharma stock price today?
The current price of TBPMQ is $0 USD — it has decreased by -99.5% in the past 24 hours. Watch Tetra Bio-Pharma stock price performance more closely on the chart.
What is Tetra Bio-Pharma stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tetra Bio-Pharma stocks are traded under the ticker TBPMQ.
What is Tetra Bio-Pharma market cap?
Today Tetra Bio-Pharma has the market capitalization of 423.36
What is Tetra Bio-Pharma revenue for the last year?
Tetra Bio-Pharma revenue for the last year amounts to 0 USD.
What is Tetra Bio-Pharma net income for the last year?
TBPMQ net income for the last year is -82.15M USD.
How many employees does Tetra Bio-Pharma have?
As of April 23, 2026, the company has 33 employees.
In which sector is Tetra Bio-Pharma located?
Tetra Bio-Pharma operates in the Health & Wellness sector.
When did Tetra Bio-Pharma complete a stock split?
The last stock split for Tetra Bio-Pharma was on June 23, 2014 with a ratio of 1:2.
Where is Tetra Bio-Pharma headquartered?
Tetra Bio-Pharma is headquartered in Orléans, Canada.